Hims & Hers Health Inc. (HIMS) Q1 2026 (USD): EPS -0.40 (exp. 0.04), Revenue 608mln (exp. 617mln)

Hims & Hers Health reported a significant miss on both earnings per share and revenue for Q1 2026, raising immediate concerns about its profitability.

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

UAE has carried out military strikes on Iran, according to WSJ citing sources; UAE strikes have included attack on a refinery on Iran's Lavan Island back in early April

Guardian's Elgot says "Understand from cabinet sources that for the moment they are not planning to quit or try to force the prime minister into a corner, they just want him to “look again” at the political reality."

Hims & Hers Health Inc. (HIMS) Q1 2026 (USD): EPS -0.40 (exp. 0.04), Revenue 608mln (exp. 617mln)

Simon Property Group Inc. (SPG) Q1 2026 (USD) EPS 1.48 (exp. 1.46), FFO/Shr 2.91 (exp. 3.01), Revenue 1.76bln (exp. 1.54bln)

Newsquawk US Market Wrap: Oil gains as Trump weighs next options, while Semis lead Tech higher

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Guidance:

  • Q2 adj. EBITDA 35-55mln (exp. 70.1mln).
  • Q2 revenue 680-700mln (exp. 643mln).
  • FY adj. EBITDA 275-300mln (exp. 322.8mln).
  • FY revenue 2.8-3bln (exp. 2.75bln)
Context

While the company has estimated better-than-expected revenue guidance for Q2, the adjusted EBITDA outlook falls short of expectations, highlighting potential challenges ahead that may pressure the stock. Investors should assess how these results might influence market sentiment towards HIMS and its guidance's credibility.

Related headlines

The whole workspace, free to try.

Try it free